Discover B2B companies, suppliers, and manufacturers related to this keyword category
Cellectis is developing life-changing product candidates to target and eradicate cancer cells.
First in RNA-guided genome editing. Patented. More Precise, Safer and more Flexible than any other platform.
Developing human-compatible organs for transplantation. Transforming Transplantation. 🧬
Realising the potential of genome rewriting to drive the next generation of bioprocesses and biopharmaceuticals
Developing the Next Generation Gene Editing Technology
BIOLOGICAL RELEVANCE. ENGINEERED PRECISION.